Selectis Health (GBCS) Gains from Investment Securities (2011 - 2024)

Selectis Health (GBCS) has 11 years of Gains from Investment Securities data on file, last reported at $2.1 million in Q2 2024.

• Quarterly Gains from Investment Securities changed N/A year-over-year to $2.1 million in Q2 2024, while the trailing twelve-month figure through Dec 2024 was $2.1 million (changed N/A YoY) and the FY2024 annual result came in at $2.1 million, changed N/A from the prior year.
• Gains from Investment Securities rose to $2.1 million in Q2 2024 per GBCS's latest filing, from $60000.0 in the prior quarter.
• The five-year high for Gains from Investment Securities was $2.1 million in Q2 2024, with the low at $60000.0 in Q4 2021.
• Average Gains from Investment Securities over 4 years is $551492.7, with a median of $238406.5 recorded in 2020.
• Year-over-year, Gains from Investment Securities jumped 5754.15% in 2020 and slumped 77.84% in 2021.
• Selectis Health's Gains from Investment Securities stood at $270813.0 in 2020, then tumbled by 77.84% to $60000.0 in 2021, then changed by 0.0% to $60000.0 in 2022, then jumped by 3420.24% to $2.1 million in 2024.
• Business Quant data shows GBCS's Gains from Investment Securities at $2.1 million in Q2 2024, $60000.0 in Q4 2022, and $206000.0 in Q2 2022.